Cytokeratin 19 Antibody (A53-B/A2.26 + BA17), FITC, Novus Biologicals™

Cytokeratin 19

Monoclonal

FITC

PBS with 0.05% Sodium Azide

KRT19

Human breast cancer MCF-7 cells (A53-B/A2); Human mammary epithelial organoids (BA17)

0.1 mL

Cancer, Cell Biology, Cellular Markers, Neuroscience, Stem Cell Markers

This monoclonal antibody reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40kDa. CK19 is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50%-60% of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.

Store at 4°C in the dark.

Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin)

A53-B/A2.26 + BA17

Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen

40-kDa keratin intermediate filament, CK19, CK-19, cytokeratin 19, K19, K1CS, keratin 19, keratin, type I cytoskeletal 19, keratin, type I, 40-kd, Keratin-19, MGC15366

Mouse

Protein A or G purified

RUO

Primary

Human

IgG2a λ, IgG1 κ